Zimmer Biomet Holdings, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Zimmer Biomet Holdings, Inc. stock analysis ZBH overview
Somewhat Bullish +50

10 Stocks Reeling From Huge Losses

📉 Ten stocks declined sharply on Tuesday as Wall Street's major indices finished in the red, with the Nasdaq leading the drop at 0.90 percent.

🏥 Zimmer Biomet Holdings Inc. (NYSE:ZBH) fell to a new 13-year low and dropped 10.53% despite strong Q1 earnings due to the immediate departure of its CFO.

👔 The CFO, Suketu Upadhyay, stepped down after seven years to pursue another opportunity, with Chief Accounting Officer Paul Stellato serving as interim replacement.

📈 Zimmer Biomet reported a 30.8% net income jump to $238.1 million and a 9.3% sales increase to $2.09 billion in the first quarter.

🧬 Qiagen NV (NYSE:QGEN) nosedived 10.7% to a seven-year low amid a lowered growth outlook caused by Middle East tensions impacting its QuantiFERON blood test sales.

📉 Qiagen revised its full-year 2026 net sales growth outlook down to 1% to 2% and decreased Adjusted EPS guidance to $2.43 from $2.50.

🏢 Alexandria Real Estate Equities Inc. (NYSE:ARE) shed 11.30% after a bearish downgrade from BNP Paribas, which cut its price target by 13.6% to $44.

📉 Although Alexandria posted strong net profits of $358.87 million in Q1, occupancy rates dropped to 87.7% and the company lowered its full-year occupancy outlook.

⚽ Sportradar Group (NASDAQ:SRAD) fell to a new 52-week low after missing revenue estimates and receiving a price target downgrade from Guggenheim Securities.

📉 Sportradar revenues reached €347 million, exceeding year-on-year growth but missing analyst expectations due to player-friendly outcomes and foreign currency headwinds.

💸 The company's adjusted EBITDA of €66 million also missed estimates of €68 million, while it reported an attributable net loss of €6.286 million compared to a prior profit.

🏗️ The article notes that the list of ten worst-performing stocks only includes companies with at least $2 billion in market capitalization and 5 million shares in trading volume.

Bullish Signals
  • Zimmer Biomet reported a strong earnings performance in the first quarter, with net income jumping 30.8% to $238.1 million versus $182 million in the same period last year.
  • Net sales increased by 9.3% to $2.09 billion from $1.909 billion year-on-year, demonstrating robust revenue growth despite broader market declines.
  • The company appointed Paul Stellato as interim CFO to provide continuity and steady direction during the transition, ensuring management stability.
  • Chairman and CEO Ivan Tornos expressed confidence in the leadership team's ability to execute strategy and deliver on commitments during this period.
Risk Factors
  • Shares of Zimmer Biomet Holdings Inc. (NYSE:ZBH) plummeted to a new 13-year low, dropping 10.53 percent, despite reporting strong Q1 earnings, due to investor concerns over the immediate departure of its CFO Suketu Upadhyay.
  • The CFO's sudden resignation has forced Zimmer Biomet to rely on interim replacement Paul Stellato while searching for a permanent candidate, creating uncertainty about leadership stability and strategic continuity.
  • Shares of Alexandria Real Estate Equities Inc. (NYSE:ARE) fell to a nearly 17-year low, shedding over 11 percent, as the stock was downgraded by BNP Paribas following a decline in occupancy rates from 91.7% to 87.7%.
  • Alexandria Real Estate lowered its full-year occupancy rate outlook to a range of 86.2% to 87.8%, missing previous guidance, and increased its projected net operating loss margin to between 8.5% and 10.5%. The company's stock dropped nearly 17 percent, shedding 11.30 percent.
  • Shares of Sportradar (NASDAQ:SRAD) crashed to a new 52-week low, dropping over 14 percent after missing revenue expectations due to unfavorable outcomes and headwinds.
  • Sportradar reported a full-year net loss of €6.286 million, reversing a profit of €24.2 million from the prior year, which contributed significantly to its sharp stock decline despite some revenue growth.
  • The broader market downturn saw all three major indices finish in the red, with the Nasdaq leading the drop by 0.90 percent and the S&P 500 declining 0.49 percent.
  • Investors are reacting negatively to corporate news headlines, causing a sharp sell-off across ten major stocks including Zimmer Biomet, Alexandria Real Estate, and Sportradar.
Full Analysis
On Tuesday, Wall Street's three major indices closed in the red as investors reacted to a wave of negative corporate news, with the Nasdaq leading the decline at 0.90 percent, followed by the S&P 500 down 0.49 percent and the Dow Jones dipping 0.05 percent. A specific list of ten worst-performing stocks was compiled based on criteria requiring a market capitalization of at least $2 billion and trading volume of 5 million shares or more. The article details that several companies experienced significant drops due to disappointing earnings, leadership changes, or downgrades from investment firms, often overriding positive fundamental data in the short term. At the bottom of this list is Zimmer Biomet Holdings Inc. (NYSE:ZBH), which tumbled to a new 13-year low, dropping 10.53 percent to close at $82.84 per share. Despite reporting strong first-quarter earnings with net income jumping 30.8 percent to $238.1 million and net sales increasing 9.3 percent to $2.09 billion, the stock plummeted after the immediate departure of its chief finance officer, CFO Suketu Upadhyay. The company announced that Upadhyay stepped down to pursue a new opportunity; Chairman, President, and CEO Ivan Tornos noted confidence in interim Chief Accounting Officer Paul Stellato to provide continuity during the search for a permanent replacement. Upadhyay's seven-year tenure was briefly acknowledged by leadership before his exit rattled investors. Other stocks on the list faced sharp declines driven by downgrades and lowered growth outlooks. Qiagen NV (NYSE:QGEN) nosedived 10.7 percent to a seven-year low of $34.02 as investors soured on its lower growth forecast, which was trimmed to a full-year 2026 net sales range of 1 to 2 percent from a previous expectation of 5 percent due to tensions in the Middle East affecting immigration testing demand. Alexandria Real Estate Equities Inc. (NYSE:ARE) fell nearly 17 percent to $40.41 after BNP Paribas downgraded its price target by 13.6 percent, citing a drop in first-quarter occupancy rates to 87.7 percent and a lowered outlook for the full year. Meanwhile, Sportradar Group (NASDAQ:SRAD) reached a 52-week low after missing revenue estimates of €367 million with actuals of €347 million, resulting in Guggenheim Securities cutting its price target by 14.3 percent despite maintaining a buy rating.